Pradžia › Geltonosios dėmės degeneracija › Florida
Geltonosios dėmės degeneracija klinikiniai tyrimai Florida
14 tyrimai dėl Geltonosios dėmės degeneracija ieško dalyvių vietose Florida.
Miestai Florida
- Pensacola5 tyrimai
- Fort Lauderdale5 tyrimai
- Tampa5 tyrimai
- Orlando5 tyrimai
- Sarasota4 tyrimai
- Jacksonville4 tyrimai
- St. Petersburg4 tyrimai
- Gainesville3 tyrimai
- Lakeland3 tyrimai
- Cape Coral3 tyrimai
Oficialus tyrimo tekstas (anglų kalba)
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
- Florida Eye Clinic (Site 130), Altamonte Springs
- Retina Group of Florida (Site 070), Fort Lauderdale
- Vitreo Retinal Associates, Gainesville
- ir dar 10
Renkami dalyviai2/3 fazė
Amžius 50 ir vyresni · Visoms lytims · Atnaujinta 2026-10-02 · NCT07440225A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
- Retina Group of Florida, Fort Lauderdale
- VitreoRetinal Associates, PA, Gainesville
- Retina Specialty Institute, Pensacola
- ir dar 1
Renkami dalyviai2/3 fazė
Amžius 60 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT06635148A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
- Advanced Retina Institute-Ophthalmology, Bonita Springs
- Advanced Research, Coral Springs
- Retina Group of Florida, Fort Lauderdale
- ir dar 11
Renkami dalyviai3 fazė
Amžius nuo 50 iki 85 · Visoms lytims · Atnaujinta 2026-09-18 · NCT06541704A Phase 2 Study of NT-101 Topical in Patients With Wet AMD
- Advanced Retina Institute, Bonita Springs
Renkami dalyviai2 fazė
Amžius 50 ir vyresni · Visoms lytims · Atnaujinta 2026-09-16 · NCT07811726Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
- Florida Retina Institute, Orlando
- Retina Specialty Institute, Pensacola
- Retina Group of Florida, Sarasota
- ir dar 1
Renkami dalyviai2 fazė
Amžius 55 ir vyresni · Visoms lytims · Atnaujinta 2026-09-10 · NCT06659445A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- Retina Specialty Institute, Pensacola
Renkami dalyviai1 fazė
Amžius 50 ir vyresni · Visoms lytims · Atnaujinta 2026-09-03 · NCT03178149A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults
- University of Florida Health - UF Health Jacksonville, Jacksonville
- University of Miami Health System - Bascom Palmer Eye Institute, Miami
Renkami dalyviaiStebimasis tyrimas
Amžius 6 ir vyresni · Visoms lytims · Atnaujinta 2026-08-25 · NCT074255744D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
- Retina Group of Florida, Fort Lauderdale
- Vitreo Retinal Associates, Gainesville
- Florida Eye Associates, Melbourne
- ir dar 2
Renkami dalyviai1/2 fazė
Amžius 50 ir vyresni · Visoms lytims · Atnaujinta 2026-08-21 · NCT05197270A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
- Retina Group of Florida, Fort Myers
- Florida Retina Institute, Orlando
- Retina Group of Florida (Site 065), Sarasota
- ir dar 1
Renkami dalyviai2/3 fazė
Amžius 50 ir vyresni · Visoms lytims · Atnaujinta 2026-08-06 · NCT07496567Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration
- Adverum site 124, Deerfield Beach
- Adverum site 176, Fort Lauderdale
- Adverum site 168, Jacksonville
Renkami dalyviai2 fazė
Amžius 50 ir vyresni · Visoms lytims · Atnaujinta 2026-08-05 · NCT07630649Stem Cell Ophthalmology Treatment Study II
- MD Stem Cells, Coral Springs
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-06-29 · NCT03011541Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
- ClearVista Clinical Research, Hudson
- Florida Retina Institute, Orlando
- Retina Specialty Institute, Pensacola
- ir dar 3
Renkami dalyviai3 fazė
Amžius 50 ir vyresni · Visoms lytims · Atnaujinta 2026-04-16 · NCT07064759Study to Evaluate the Safety of CG-P5 Peptide Eye Drops in Patients Diagnosed With Age-related Wet Macular Degeneration
- CBCC Global Research Site:006, Deerfield Beach
Renkami dalyviai1 fazė
Amžius 50 ir vyresni · Visoms lytims · Atnaujinta 2025-02-07 · NCT06132035Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
- Sarasota Retina Institute, Sarasota
Renkami dalyviai
Amžius 65 ir vyresni · Visoms lytims · Atnaujinta 2024-12-03 · NCT05438732Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.